These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19130494)

  • 21. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells.
    Chang CM; Kao CL; Chang YL; Yang MJ; Chen YC; Sung BL; Tsai TH; Chao KC; Chiou SH; Ku HH
    Biochem Biophys Res Commun; 2007 Jun; 357(2):414-20. PubMed ID: 17433254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative screening of embryonic stem cell differentiation: endoderm formation as a model.
    Chang KH; Zandstra PW
    Biotechnol Bioeng; 2004 Nov; 88(3):287-98. PubMed ID: 15486933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways to new beta cells.
    Zhou Q; Melton DA
    Cold Spring Harb Symp Quant Biol; 2008; 73():175-81. PubMed ID: 19478324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic stellate cells can form new beta-like cells.
    Docherty K
    Biochem J; 2009 Jun; 421(2):e1-4. PubMed ID: 19552623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo.
    Naujok O; Francini F; Picton S; Bailey CJ; Lenzen S; Jörns A
    Diabetes Metab Res Rev; 2009 Jul; 25(5):464-76. PubMed ID: 19425055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cells and diabetes treatment.
    Madsen OD
    APMIS; 2005; 113(11-12):858-75. PubMed ID: 16480455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of human insulin-producing cells for cell therapy of diabetes.
    Russ HA; Efrat S
    Pediatr Endocrinol Rev; 2011 Dec; 9(2):590-7. PubMed ID: 22397143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of activin on mouse embryonic stem cell differentiation in insulin-secreting cells under nestin-positive selection and spontaneous differentiation protocols.
    Jafary H; Larijani B; Farrokhi A; Pirouz M; Mollamohammadi S; Baharvand H
    Cell Biol Int; 2008 Feb; 32(2):278-86. PubMed ID: 18023369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cells and pancreatic differentiation in vitro.
    Blyszczuk P; Wobus AM
    J Biotechnol; 2004 Sep; 113(1-3):3-13. PubMed ID: 15380643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scalable production of pancreatic islet progenitors for diabetes cell therapies.
    Lock LT; Tzanakakis ES
    Med J Malaysia; 2008 Jul; 63 Suppl A():5-6. PubMed ID: 19024957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet- and stem-cell-based tissue engineering in diabetes.
    Montanya E
    Curr Opin Biotechnol; 2004 Oct; 15(5):435-40. PubMed ID: 15464374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are stem cells a cure for diabetes?
    McCall MD; Toso C; Baetge EE; Shapiro AM
    Clin Sci (Lond); 2009 Oct; 118(2):87-97. PubMed ID: 19807695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regenerative medicine: using liver to generate pancreas for treating diabetes.
    Meivar-Levy I; Ferber S
    Isr Med Assoc J; 2006 Jun; 8(6):430-4. PubMed ID: 16833177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making β cells from adult tissues.
    Efrat S; Russ HA
    Trends Endocrinol Metab; 2012 Jun; 23(6):278-85. PubMed ID: 22537825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward a renewable source of pancreatic beta-cells.
    Ricordi C; Edlund H
    Nat Biotechnol; 2008 Apr; 26(4):397-8. PubMed ID: 18392020
    [No Abstract]   [Full Text] [Related]  

  • 36. Generating mature β-cells from embryonic stem cells: strategies for late-stage differentiation.
    Champeris Tsaniras S
    Vitam Horm; 2011; 87():79-92. PubMed ID: 22127238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of amniotic stem cell lines with potential for therapy.
    De Coppi P; Bartsch G; Siddiqui MM; Xu T; Santos CC; Perin L; Mostoslavsky G; Serre AC; Snyder EY; Yoo JJ; Furth ME; Soker S; Atala A
    Nat Biotechnol; 2007 Jan; 25(1):100-6. PubMed ID: 17206138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse ES cells over-expressing the transcription factor NeuroD1 show increased differentiation towards endocrine lineages and insulin-expressing cells.
    Marchand M; Schroeder IS; Markossian S; Skoudy A; Nègre D; Cosset FL; Real P; Kaiser C; Wobus AM; Savatier P
    Int J Dev Biol; 2009; 53(4):569-78. PubMed ID: 19378248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus.
    Soria B; Skoudy A; Martín F
    Diabetologia; 2001 Apr; 44(4):407-15. PubMed ID: 11357469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.